Weaning from high-flow nasal cannula in adults
Part of Lungs & breathing clinical trials.
This study tests a step-by-step plan to safely reduce and stop high-flow nasal cannula oxygen therapy in adults who are stable enough to start weaning. It may help you breathe on your own sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been on high-flow nasal cannula for at least 12 hours because of low oxygen levels and hard work breathing
- Your medical team thinks it is safe to start weaning you off the high-flow oxygen
- Your breathing and oxygen levels are stable (respiratory rate ≤25, oxygen saturation >90%, oxygen setting ≤80%)
- You are not on a breathing machine or ECMO, and you do not need continuous inhaled medicines through the nasal cannula
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a scoring system (ROX Index) to help decide the best timing to place a breathing tube (intubate) for adults who are struggling to get enough oxygen while using nasal high-flow (NHF). The goal is to see if using this timing approach can improve care for acute lung failure in the ICU.
This trial is testing a way to safely reduce high-flow oxygen therapy for patients in the ICU who have low oxygen levels. It might help find the right time to stop this treatment.
This study helps doctors predict which patients receiving high-flow oxygen through a nasal tube will need additional breathing support. Researchers use blood tests and clinical information to identify who might need a ventilator, allowing earlier interventions if needed.
This trial studies a continuous negative external pressure device (a “cuirass” that helps breathing) for people with sudden, severe low oxygen levels. It aims to see whether the device improves breathing and oxygen levels without needing immediate intubation.
This trial compares two different approaches to gradually reducing high-flow nasal oxygen therapy (a breathing support treatment delivered through your nose) in patients with acute respiratory failure. The goal is to find the best way to safely stop this treatment and transition you to breathing on your own.
This trial tests whether babies with bronchiolitis who have been on a high-flow nasal cannula (a breathing tube) for at least 12 hours can safely stop it. It aims to find a better way to wean babies off this breathing support.
Hear when a new Acute Hypoxemic Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.